Scholar Rock Holding Corporation — 財務諸表 (NASDAQ:SRRK) | MetaTrader

チャート全体を表示

ニュース

SRRK Stock Jumps on Resubmission of FDA Filing for SMA Drug

Scholar Rock Holding Corporation (SRRK) Discusses BLA Resubmission for Apitegromab in Spinal Muscular Atrophy and Regulatory Progress Transcript

Scholar Rock: From Manufacturing Hurdle To Commercial Muscle, Maintaining Buy Rating (NASDAQ:SRRK)

JPモルガン・チェース・アンド・カンパニー、医薬品承認見通しを受けScholar Rock株の目標株価を引き上げ

JPMorgan raises Scholar Rock stock price target on drug approval outlook

Scholar Rock、Leerink会議でFDA承認遅延の中での戦略的方針を提示

Scholar Rock at Leerink Conference: Strategic Path Amid FDA Delays

Piper SandlerがScholar Rock株の目標株価を引き上げ、SMA治療薬の発売を見据える

Piper Sandler raises Scholar Rock stock price target on SMA launch

バークレイズが債務契約を受けてScholar Rock株の目標株価を53ドルに引き上げ

Barclays raises Scholar Rock stock price target to $53 on debt deal

Truist、製造進捗を受けてScholar Rock株の目標株価を引き上げ